Humana Posts Q4 Net Loss of $5.76 Per Share, Reaffirms 2025 Outlook
Humana reported a fourth-quarter 2024 GAAP net loss of $5.76 per share, compared with a $4.42 loss a year earlier, while fourth-quarter revenue rose to $29.2 billion from $26.5 billion. The company reaffirmed its 2025 outlook, with GAAP EPS guidance of approximately $15.88 and an expected individual Medicare Advantage membership decline of approximately 550,000. Shareholders face a wider quarterly loss and lower full-year EPS, partly offset by higher revenue and unchanged 2025 guidance.
Key points
- 4Q24 GAAP net loss per share of $5.76 versus $4.42 in 4Q23; Adjusted net loss per share of $2.16 versus $0.11 in 4Q23
- FY 2024 GAAP EPS of $9.98 versus $20.00 in FY 2023; Adjusted EPS of $16.21 versus $26.09
- 4Q24 GAAP revenue of $29.2 billion versus $26.5 billion in 4Q23; FY 2024 revenue of $117.8 billion versus $106.4 billion
- FY 2025 GAAP EPS guidance of approximately $15.88 (Adjusted approximately $16.25); individual Medicare Advantage membership expected to decline by approximately 550,000
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 11, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.